InnoCan Pharma Corporation (CSE:INNO)

Canada flag Canada · Delayed Price · Currency is CAD
6.93
+0.08 (1.17%)
At close: Feb 27, 2026
-46.69%
Market Cap 31.18M
Revenue (ttm) 37.64M
Net Income (ttm) -4.50M
Shares Out 4.50M
EPS (ttm) -1.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 400
Average Volume 2,476
Open 6.93
Previous Close 6.85
Day's Range 6.93 - 6.93
52-Week Range 5.76 - 21.00
Beta 0.02
RSI 42.97
Earnings Date Mar 31, 2026

About InnoCan Pharma

InnoCan Pharma Corporation, a pharmaceutical technology company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Canada, Europe, and internationally. The company operates in two segments: Online Sales and Other Operations. It engages in the research and development of CBD loaded exosomes, as well as operates LPT CBD-loaded liposome platform that facilitates exact dosing and the prolonged and controlled release of CBD into the blood stream for e... [Read more]

Founded 2018
Employees 5
Stock Exchange Canadian Securities Exchange
Ticker Symbol INNO
Full Company Profile

Financial Performance

In 2024, InnoCan Pharma's revenue was $29.44 million, an increase of 115.55% compared to the previous year's $13.66 million. Losses were -$1.83 million, -60.98% less than in 2023.

Financial numbers in USD Financial Statements

News

There is no news available yet.